Investment Commentary

Input your email to stay up to date on our investment commentary!

This field is for validation purposes and should be left unchanged.

Mainstreaming of Alternative Assets

“Alternatives are all the rage,” said Barron’s Magazine in the Up and Down Wall Street column on October 14th. It has also been “heard on Wall Street” that all the…

More Discriminating With Every Dollar…

Consumers have delivered a message to consumer products companies: enough is enough with higher prices. To their credit, the companies seemed to have listened as evidenced by McDonald’s $5 value…

What Is Industrial Policy And Is It Good For Us?

Much has been written recently and spoken about threats to democracy. How about threats to capitalism and our free market economies by events taking place around the world? This essay…

At The Halfway Mark…

The year is half over and so far, stock markets around the world have done quite a bit better than most prognosticators earlier anticipated. The driving forces year-to-date have been…

GLP Drugs: An Investor’s Perspective

Introduction Continuing our exploration of GLP-1 weight-loss drugs (GLP-1 Part 1) https://www.baldwinmgt.com/glp-1-weight-loss-drugs-overhyped-or-a-gamechanger/ , we will review recent developments that further boost credibility and excitement about the GLP-1 class of drugs,…
Menu